MedPath

Effects of Tai Chi on Multisite Pain and Brain Functions in Older Adults

Not Applicable
Completed
Conditions
Chronic Pain
Interventions
Behavioral: Light Exercise
Behavioral: Tai Chi
Registration Number
NCT03086772
Lead Sponsor
University of Massachusetts, Boston
Brief Summary

The main purpose of this randomized controlled trial was to assess the feasibility and acceptability of a 12-week Tai Chi program for community-dwelling older adults with chronic multisite pain and a history of falling. In addition, the investigators examined the effects of Tai Chi on pain characteristics, cognition, physical function, gait mobility, levels of pain-related biomarkers, fear of falling and rate of falls in these older adults.

Detailed Description

Older adults aged ≥65 years with multisite pain who reported falling in the past year or current use of an assistive device were recruited from Boston area communities. Participants were randomized to either a Tai Chi (N=28) or a light physical exercise (N=26) program, offered twice weekly for 12 weeks. The primary outcomes were feasibility and acceptability of the 12-week Tai Chi/light exercise program. Secondary outcomes included pain characteristics (pain severity and pain interference), cognition (attention and executive function), physical function (walking speed, strength, and balance), gait mobility (singe-task and dual-task gait), levels of pain-related markers (C-reactive protein, interleukin 6, tumor necrosis factor alpha, and beta endorphin), fear of falling, and rate of falls.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Age of 65 years and older
  • Multisite (2 or more sites) musculoskeletal pain
  • At least one fall in the past year, or currently on an assistive device
  • A sedentary lifestyle
  • Be able to walk 20-feet without personal assistance
  • Be able to communicate in English.
Exclusion Criteria
  • Regular Tai Chi practice
  • Unstable cardiac disease
  • Stroke
  • Rheumatoid arthritis
  • Degenerative neuromuscular disease
  • Parkinson's disease
  • Terminal disease
  • Dementing illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Light ExerciseLight ExerciseIndividuals in the exercise control group performed a 12-week light exercise program.
Tai ChiTai ChiIndividuals in the Tai Chi intervention group participated in a 12-week Tai Chi program.
Primary Outcome Measures
NameTimeMethod
Feasibility and acceptability of the 12-week Tai Chi programOver the 12-week intervention period

Feasibility and acceptability were evaluated by adherence, attendance, optimal program components, and safety.

Secondary Outcome Measures
NameTimeMethod
Gait mobilityBefore and after the 12-week intervention period

Single-task and dual-task gait function was determined by using the PKMAS software and Zeno walkway.

Fear of fallingBefore and after the 12-week intervention period

Fear of falling was measured using the Tinetti Falls Effi- cacy Scale.

Pain characteristicsBefore and after the 12-week intervention period

Pain severity and interference were evaluated by using the Brief Pain Inventory (BPI) questionnaire.

Physical functionBefore and after the 12-week intervention period

Physical function was measured by using the Short Physical Performance Battery (SPPB)

Rate of fallsOver the 12-week intervention and 6 months following the intervention

Rate of falls were recorded by using monthly fall calendars.

CognitionBefore and after the 12-week intervention period

Attention was evaluated by using the Test of Everyday Attention (TEA) questionnaire. Executive function was evaluated by using the Trailmaking A and B tests questionnaire.

Pain-related biomarkersBefore and after the 12-week intervention period

Levels of inflammatory markers and beta endorphin were determined by using biochemistry assays.

Trial Locations

Locations (1)

University of Massachusetts, Boston

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath